Aberrations of TP53 or p16INK4/p14ARF, although rare, are associated with decreased overall survival and have been the strongest negative predictor of outcome in ES, even more than the presence of metastases at diagnosis in multivariate analysis [22]. This evidence concerns the gene TP53 and Ewing sarcoma.